Welcome to our dedicated page for Blade Air Mobility news (Ticker: $BLDE), a resource for investors and traders seeking the latest updates and insights on Blade Air Mobility stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Blade Air Mobility's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Blade Air Mobility's position in the market.
Blade Air Mobility reported strong financial results for the first quarter ended March 31, 2024. The company achieved record-high Medical revenue of $36.0 million, a 34.6% increase from the prior year. Net loss improved by $6.0 million to $(4.2) million. Adjusted EBITDA also improved significantly. Blade confirmed guidance for Adjusted EBITDA profitability in 2024 and double-digit millions for 2025.